Treg cell therapy showing promise in ALS trials: Coya Therapeutics 02-Aug-2021 By Jenni Spinner According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.
BIO Digital 2021 Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment 01-Jun-2021 By Jenni Spinner The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization.